Literature DB >> 27062902

Loss of Peristaltic Reserve, Determined by Multiple Rapid Swallows, Is the Most Frequent Esophageal Motility Abnormality in Patients With Systemic Sclerosis.

Dustin A Carlson1, Michael D Crowell2, Jessica N Kimmel1, Amit Patel3, C Prakash Gyawali3, Monique Hinchcliff4, W Leroy Griffing5, John E Pandolfino1, Marcelo F Vela6.   

Abstract

We assessed peristaltic reserve using multiple rapid swallows (MRS) during esophageal high-resolution manometry (HRM) of 111 patients with systemic sclerosis (89 women; ages, 42-64 y). We performed a retrospective analysis of HRM studies that included MRS in patients with systemic sclerosis, performed at 2 tertiary referral centers, and compared data with those from 18 healthy volunteers (controls). HRM findings were analyzed according to the Chicago Classification to provide an esophageal motility diagnosis. Response to MRS was evaluated for the presence of contraction and for augmentation, defined as the distal contractile integral after MRS greater than the median distal contractile integral of 10 supine swallows. Esophageal motility diagnoses included 41% with absent contractility, 31% with normal motility, 23% with ineffective esophageal motility, and 5% that met the criteria for other esophageal motility disorders. Contraction (37%) and peristaltic augmentation (18%) after MRS were observed less frequently in patients with systemic sclerosis than in controls (83% and 100%, respectively). Impaired peristaltic reserve, as assessed with MRS during HRM, is therefore the most common esophageal motility finding among patients with systemic sclerosis.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Esophageal Motility; High-Resolution Manometry; Systemic Sclerosis

Mesh:

Year:  2016        PMID: 27062902      PMCID: PMC5028229          DOI: 10.1016/j.cgh.2016.03.039

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  21 in total

1.  Failure to respond to physiologic challenge characterizes esophageal motility in erosive gastro-esophageal reflux disease.

Authors:  C Daum; R Sweis; E Kaufman; A Fuellemann; A Anggiansah; M Fried; M Fox
Journal:  Neurogastroenterol Motil       Date:  2011-01-28       Impact factor: 3.598

2.  SCLERODERMA OF THE ESOPHAGUS. A CORRELATION OF HISTOLOGIC AND PHYSIOLOGIC FINDINGS.

Authors:  W L TREACY; A H BAGGENSTOSS; C H SLOCUMB; C F CODE
Journal:  Ann Intern Med       Date:  1963-09       Impact factor: 25.391

3.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

Review 4.  Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.

Authors:  Saowanee Ngamruengphong; Grigorios I Leontiadis; Saba Radhi; Andrew Dentino; Kenneth Nugent
Journal:  Am J Gastroenterol       Date:  2011-04-12       Impact factor: 10.864

5.  EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Authors:  O Kowal-Bielecka; R Landewé; J Avouac; S Chwiesko; I Miniati; L Czirjak; P Clements; C Denton; D Farge; K Fligelstone; I Földvari; D E Furst; U Müller-Ladner; J Seibold; R M Silver; K Takehara; B Garay Toth; A Tyndall; G Valentini; F van den Hoogen; F Wigley; F Zulian; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2009-01-15       Impact factor: 19.103

Review 6.  Gastrointestinal motility disorders in scleroderma.

Authors:  R W Sjogren
Journal:  Arthritis Rheum       Date:  1994-09

Review 7.  Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).

Authors:  H Sallam; T A McNearney; J D Z Chen
Journal:  Aliment Pharmacol Ther       Date:  2006-03-15       Impact factor: 8.171

Review 8.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  M Abu-Shakra; F Guillemin; P Lee
Journal:  Semin Arthritis Rheum       Date:  1994-08       Impact factor: 5.532

9.  A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma).

Authors:  C G P Roberts; L K Hummers; W J Ravich; F M Wigley; G M Hutchins
Journal:  Gut       Date:  2006-03-09       Impact factor: 23.059

10.  Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth.

Authors:  C Jacobs; E Coss Adame; A Attaluri; J Valestin; S S C Rao
Journal:  Aliment Pharmacol Ther       Date:  2013-04-10       Impact factor: 8.171

View more
  23 in total

Review 1.  Neuronal Control of Esophageal Peristalsis and Its Role in Esophageal Disease.

Authors:  K Nikaki; A Sawada; A Ustaoglu; D Sifrim
Journal:  Curr Gastroenterol Rep       Date:  2019-11-23

2.  Relationship between esophageal motility abnormalities and skin or lung involvements in patients with systemic sclerosis.

Authors:  Shiko Kuribayashi; Sei-Ichiro Motegi; Kenichiro Hara; Yasuyuki Shimoyama; Hiroko Hosaka; Akiko Sekiguchi; Kouichi Yamaguchi; Osamu Kawamura; Takeshi Hisada; Osamu Ishikawa; Motoyasu Kusano; Toshio Uraoka
Journal:  J Gastroenterol       Date:  2019-04-01       Impact factor: 7.527

Review 3.  Chicago Classification of Esophageal Motility Disorders: Applications and Limits in Adults and Pediatric Patients with Esophageal Symptoms.

Authors:  Kornilia Nikaki; Joanne Li Shen Ooi; Daniel Sifrim
Journal:  Curr Gastroenterol Rep       Date:  2016-11

Review 4.  The role of high-resolution manometry in the assessment of upper gastrointestinal involvement in systemic sclerosis: a systematic review.

Authors:  Wouter Schutyser; Ludovic Cruyt; Jean-Baptiste Vulsteke; Jan L Lenaerts; Ellen De Langhe
Journal:  Clin Rheumatol       Date:  2019-11-11       Impact factor: 2.980

Review 5.  High-resolution esophageal manometry: interpretation in clinical practice.

Authors:  Rena Yadlapati
Journal:  Curr Opin Gastroenterol       Date:  2017-07       Impact factor: 3.287

Review 6.  Gastrointestinal and Hepatic Disease in Systemic Sclerosis.

Authors:  Tracy M Frech; Diane Mar
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

7.  Esophageal high-resolution impedance manometry alterations in asymptomatic patients with systemic sclerosis: prevalence, associations with disease features, and prognostic value.

Authors:  Serena Vettori; Salvatore Tolone; Domenico Capocotta; Rossella Chieffo; Veronica Giacco; Gabriele Valentini; Ludovico Docimo
Journal:  Clin Rheumatol       Date:  2018-02-13       Impact factor: 2.980

8.  Mechanisms of repetitive retrograde contractions in response to sustained esophageal distension: a study evaluating patients with postfundoplication dysphagia.

Authors:  Dustin A Carlson; Peter J Kahrilas; Katherine Ritter; Zhiyue Lin; John E Pandolfino
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-12-21       Impact factor: 4.052

Review 9.  Minor esophageal functional disorders: are they relevant?

Authors:  Ryan A Balko; Don C Codipilly; Karthik Ravi
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-17

Review 10.  GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis.

Authors:  Marie-Pier Tétreault; Peter Kahrilas
Journal:  Curr Rheumatol Rep       Date:  2019-07-03       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.